Selective Serotonin Reuptake Inhibitors and the Risk of Cataracts. A Nested Case-Control Study

Ophthalmology

Volumn 117, Issue 6, 2010, Pages 1251-1255

  Etminan, Mahyar ^a,b   Mikelberg, Frederick S ^b   Brophy, James M ^c  

^a VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

AGED; AGING; ARTICLE; CANADA; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SAFETY; DRUG USE; FEMALE; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT RESPONSE;

AGED; CASE-CONTROL STUDIES; CATARACT; CATARACT EXTRACTION; CYCLOHEXANOLS; FEMALE; FLUVOXAMINE; HUMANS; MALE; PAROXETINE; PHARMACOEPIDEMIOLOGY; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 77952890322     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.11.042     Document Type: Article

References (20)

1. Ernst P., Baltzan M., Deschênes J., and Suissa S. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J 27 (2006) 1168-1174
2. Kanthan G.L., Wang J.J., Rochtchina E., and Mitchell P. Use of antihypertensive medications and topical beta-blockers and the long-term incidence of cataract and cataract surgery. Br J Ophthalmol 93 (2009) 1210-1214
3. Klein B.E., Klein R., Lee K.E., and Danforth L.G. Drug use and five-year incidence of age-related cataracts: the Beaver Dam Eye Study. Ophthalmology 108 (2001) 1670-1674
4. Ludwig J., Marcotte D.E., and Norberg K. Anti-depressants and suicide. J Health Econ 28 (2009) 659-676
5. van Walraven C., Mamdani M.M., Wells P.S., and Williams J.I. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 323 (2001) 655-658
6. Ginzburg R., and Rosero E. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants. Ann Pharmacother 43 (2009) 98-103
7. Costagliola C., Parmeggiani, and Sebastiani A. SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms. CNS Drugs 18 (2004) 475-484
8. Boerrigter R.M., Siertsema J.V., and Kema I.P. Serotonin (5-HT) and the rat's eye: some pilot studies. Doc Ophthalmol 82 (1992) 141-150
9. Levy A.R., Tamblyn R.M., Fitchett D., et al. Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. Can J Cardiol 15 (1999) 1277-1282
10. Tamblyn R., Lavoie G., Petrella L., and Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 48 (1995) 999-1009
11. Mancini G.B., Etminan M., Zhang B., et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 47 (2006) 2554-2560
12. Essebag V., Genest Jr. J., Suissa S., and Pilote L. The nested case-control study in cardiology. Am Heart J 146 (2003) 581-590
13. McCarty C.A., Mukesh B.N., Fu C.L., and Taylor H.R. The epidemiology of cataract in Australia. Am J Ophthalmol 128 (1999) 446-465
14. Vivekanandan S., and Lou M.F. Evidence for the presence of phosphoinositide cycle and its involvement in cellular signal transduction in the rabbit lens. Curr Eye Res 8 (1989) 101-111
15. Westenberg H.G., and Sandner C. Tolerability and safety of fluvoxamine and other antidepressants. Int J Clin Pract 60 (2006) 482-491
16. DrugTopics. Top 200 brand drugs by unit in 2007 (February 18, 2008). http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/072008/491207/article.pdf Accessed September 15, 2009
17. Venlafaxine. In: Repchinsky C. (Ed). CPS 2009: Compendium of Pharmaceuticals and Specialties. 44th ed. (2009), Canadian Pharmaceutical Assoc., Ottawa, Canada 787-797
18. Weinstock M., and Scott J.D. Effect of various agents on drug-induced opacities of the lens. Exp Eye Res 6 (1967) 368-375 javascript:PopUpMenu2_Set(Menu6060548)
19. Olfson M., and Marcus S.C. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66 (2009) 848-856
20. IMS reports 11.5 percent dollar growth in '03 U.S. prescription sales. [press release] (February 15, 2004), IMS Health, Fairfield, CT. http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=77c91d3be7a29110VgnVCM10000071812ca2RCRD&vgnextchannel=41a67900b55a5110VgnVCM10000071812ca2RCRD&vgnextfmt=default Accessed November 20, 2009